drugset / Trial / NCT01064141

A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines

NCT01064141

Phase 2 Completed 210 enrolled Sanofi
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to investigate the potential for co-administration of the first dose of CYD Dengue vaccine with childhood vaccination. Primary Objectives: * To describe the safety of CYD Dengue vaccine after each dose; first dose given alone or coadministered with childhood vaccines. Secondary Objectives: * To describe the immunogenicity of CYD Dengue vaccine after each dose; first dose given alone or co-administered with childhood vaccines.

Timeline

Start
2010-01
Primary completion
2012-09
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject CYD Dengue Vaccine Vaccine 0.5 ml Subcutaneous
Comparator Varicella vaccine Vaccine 0.5 ml Subcutaneous
Comparator Varicella vaccine Vaccine 0.5 ml Other
Background AVAXIM Vaccine 0.5 ml Subcutaneous